Clinical Trials > Haematology > APOLLO

  • Information
APOLLO

Title

A POLATUZUMAB VEDOTIN CONTAINING CHEMO-IMMUNOTHERAPEUTIC REGIMEN IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA UNSUITABLE FOR FULL DOSE R-CHOP THERAPY


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs
II Funded and in setup CLATTERBRIDGE Cancer Centre EUDRACT No: 2019-000842-36
ISRCTN No:

Purpose


Trial Lead Organisations


Official Title

A POLATUZUMAB VEDOTIN CONTAINING CHEMO-IMMUNOTHERAPEUTIC REGIMEN IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA UNSUITABLE FOR FULL DOSE R-CHOP THERAPY


Trial Start Date

01/01/1900


References


Trial Coordinator

Hannah Short


Trial Coordinator Email Address

hlshort@liverpool.ac.uk


Trial Coordinator Contact No


Login

Username:
Password:

Lost Username / Password?